메뉴 건너뛰기




Volumn 65, Issue 5, 2011, Pages 1059-

Written action plans should be comprehensive and evidence-based

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; CORTICOSTEROID; HYDROCORTISONE; PIMECROLIMUS; TACROLIMUS;

EID: 80054095784     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2008.10.015     Document Type: Letter
Times cited : (1)

References (5)
  • 1
    • 51349105714 scopus 로고    scopus 로고
    • Written action plans: Potential for improving outcomes in children with atopic dermatitis
    • S.S. Chisolm, S.L. Taylor, R. Balkrishnan, and S.R. Feldman Written action plans: potential for improving outcomes in children with atopic dermatitis J Am Acad Dermatol 59 2008 677 683
    • (2008) J Am Acad Dermatol , vol.59 , pp. 677-683
    • Chisolm, S.S.1    Taylor, S.L.2    Balkrishnan, R.3    Feldman, S.R.4
  • 2
    • 0037238287 scopus 로고    scopus 로고
    • Modulation of collagen synthesis and mRNA by continuous and intermittent use of topical hydrocortisone in human skin
    • P. Nuutinen, R. Riekki, M. Parikka, T. Salo, P. Autio, and J. Risteli Modulation of collagen synthesis and mRNA by continuous and intermittent use of topical hydrocortisone in human skin Br J Dermatol 148 2003 39 45
    • (2003) Br J Dermatol , vol.148 , pp. 39-45
    • Nuutinen, P.1    Riekki, R.2    Parikka, M.3    Salo, T.4    Autio, P.5    Risteli, J.6
  • 3
    • 0031657805 scopus 로고    scopus 로고
    • Tacrolimus ointment does not affect collagen synthesis: Results of a single-center randomized trial
    • S. Reitamo, J. Rissanen, A. Remitz, H. Granlund, P. Erkko, and P. Elg Tacrolimus ointment does not affect collagen synthesis: results of a single-center randomized trial J Invest Dermatol 111 1998 396 398
    • (1998) J Invest Dermatol , vol.111 , pp. 396-398
    • Reitamo, S.1    Rissanen, J.2    Remitz, A.3    Granlund, H.4    Erkko, P.5    Elg, P.6
  • 4
    • 0035081866 scopus 로고    scopus 로고
    • The new topical ascomycin derivative SDZ ASM 981 does not induce skin atrophy when applied to normal skin for 4 weeks: A randomized, double-blind controlled study
    • C. Queille-Roussel, C. Paul, L. Duteil, M.C. Lefebvre, G. Rapatz, and M. Zagula The new topical ascomycin derivative SDZ ASM 981 does not induce skin atrophy when applied to normal skin for 4 weeks: a randomized, double-blind controlled study Br J Dermatol 144 2001 507 513
    • (2001) Br J Dermatol , vol.144 , pp. 507-513
    • Queille-Roussel, C.1    Paul, C.2    Duteil, L.3    Lefebvre, M.C.4    Rapatz, G.5    Zagula, M.6
  • 5
    • 0042282540 scopus 로고    scopus 로고
    • Primary Care Dermatology Society website. Primary Care Dermatology & British Association of Dermatologists Available at:. Accessed October 3, 2008
    • Primary Care Dermatology Society website. Primary Care Dermatology & British Association of Dermatologists. Guidelines for the management of atopic eczema. Available at: http://www.pcds.org.uk/images/stories/pcdsbad-eczema.pdf. Accessed October 3, 2008.
    • Guidelines for the Management of Atopic Eczema


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.